Medical Device News Magazine

Theator Achieves HITRUST CSF® Certification for Ensuring the Highest Standards of Privacy and Compliance to Partner Healthcare Institutions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Theator, the creator of Surgical Intelligence, announced today that it has achieved the HITRUST Cyber Security Framework (CSF) certification for practicing security protocols that meet both risk- and compliance-based HITRUST CSF requirements.

HITRUST CSF is a certifiable framework that provides organizations with a comprehensive, flexible, and efficient approach to regulatory compliance and risk management. Due to the sensitive nature of healthcare data specifically and the rise in healthcare breaches this year, HITRUST CSF certification is essential for health technology vendors to instill confidence in security measures and protect the very patients they aim to help. This accomplishment demonstrates the high level of importance Theator places on privacy, security, and compliance and solidifies Theator as a leader in all three areas. With HITRUST CSF certification, Theator is committed to maintaining the highest levels of nationally and internationally accepted security and privacy-related regulatory adherence in ongoing and future projects.

“Surgical Intelligence increases visibility into the OR to better evaluate surgical best practices, so we, at Theator, have a responsibility to provide our partners and their patients with the highest levels of protection,” said Dotan Asselmann, CTO and Co-founder of Theator. “HITRUST CSF certification instills that confidence in Theator’s technology and accelerates our mission to define a new gold standard in surgical care.”

Theator created the category of Surgical Intelligence to increase OR visibility and eliminate the widespread variability and disparity plaguing the surgical field. Theator’s first-of-its-kind Surgical Intelligence Platform institutionalizes automatic and routine surgical video capture, layering footage with AI-powered analysis of every operation. Surgical stakeholders access actionable insights to deliver optimized patient outcomes, ultimately enhancing surgical best practices and raising overall standards of care.

Most recently, in July 2022, Theator announced it had closed out its Series A funding with $39.5M, having now raised a total of $42.5M. In the last year, Theator has collaborated with Mayo Clinic and partnered with the Canadian Association of General Surgeons (CAGS), adding further prestige to the burgeoning list of innovative medical institutions and surgical societies adopting Surgical Intelligence. Last December, the company was named on CB Insights’ prestigious Digital Health 150 list of the 150 most innovative digital health startups in the world, highlighting industry recognition of Surgical Intelligence as a distinct category for the first time.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”